MASS
908 Devices Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.03
−0.10%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−10.7x
Market Cap
$414.58M
MomentumView details →
1D Return
−0.10%
YTD Return
+89.25%
RSI (14)
51.5
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−10.7x
Market Cap
$414.58M
RSI (14)
51.5
MomentumView details →
1D Return
−0.10%
YTD Return
+89.25%
SummaryUpdated Jun 1, 2026
908 Devices Inc. (NASDAQ:MASS) is a commercial-stage technology company founded in 2012 and headquartered in Boston, Massachusetts. The company specializes in developing and manufacturing portable mass spectrometry and analytical devices for chemical detection and analysis. Since going public in December 2020, 908 Devices has focused on serving markets including life sciences research, bioprocessing, forensics, and industrial applications with its handheld and desktop analytical instruments.
Similar companies
Latest newsMore news →
908 Devices reported Q2 2026 revenue of $16.1 million, up 23% year over year, with adjusted EBITDA loss improving by 50%.9d ago908 Devices Inc. reported financial results for the quarter ended June 30, 2026, with revenue growing 23% year-over-year and Adjusted EBITDA loss narrowing by more than half compared to a year ago.24d ago